Loading...
XNYSCLB
Market cap790mUSD
Dec 23, Last price  
16.84USD
1D
-0.06%
1Q
-12.34%
Jan 2017
-85.97%
Name

Core Laboratories N.V.

Chart & Performance

D1W1MN
XNYS:CLB chart
P/E
21.56
P/S
1.55
EPS
0.78
Div Yield, %
0.24%
Shrs. gr., 5y
1.34%
Rev. gr., 5y
-6.17%
Revenues
510m
+4.10%
427,427,000483,467,000575,689,000670,540,000780,836,000695,539,000794,653,000907,648,000981,080,0001,073,508,0001,085,222,000797,520,000594,741,000659,809,000700,846,000668,210,000487,267,000470,252,000489,735,000509,790,000
Net income
37m
+88.53%
12,290,00031,211,00082,662,000121,105,000143,603,000113,604,000144,917,000184,684,000216,071,000242,811,000257,485,000114,847,00063,895,00083,125,00079,526,000101,983,000-97,073,00019,727,00019,453,00036,675,000
CFO
25m
-0.67%
54,196,00074,778,000120,305,000125,695,000155,207,000181,873,000205,832,000204,126,000237,202,000298,137,000303,449,000219,100,000131,887,000124,271,000111,827,00089,527,00057,868,00036,579,00024,956,00024,789,000
Dividend
Aug 05, 20240.01 USD/sh

Profile

Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. In addition, the company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. It operates approximately in 50 countries. The company was founded in 1936 and is based in Amstelveen, the Netherlands.
URL
https://www.corelab.com/
IPO date
Jul 10, 1998
Employees
3,600
Domiciled in
NL
Incorporated in
NL

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
509,790
4.10%
489,735
4.14%
470,252
-3.49%
Cost of revenue
454,635
448,933
430,585
Unusual Expense (Income)
NOPBT
55,155
40,802
39,667
NOPBT Margin
10.82%
8.33%
8.44%
Operating Taxes
4,185
10,296
15,891
Tax Rate
7.59%
25.23%
40.06%
NOPAT
50,970
30,506
23,776
Net income
36,675
88.53%
19,453
-1.39%
19,727
-120.32%
Dividends
(1,868)
(1,853)
(1,834)
Dividend yield
0.22%
0.20%
0.18%
Proceeds from repurchase of equity
(2,202)
(4,314)
50,883
BB yield
0.26%
0.45%
-4.88%
Debt
Debt current
10,175
11,699
12,342
Long-term debt
257,461
260,695
299,550
Deferred revenue
30,544
31,814
(24,336)
Other long-term liabilities
20,040
20,883
91,148
Net debt
247,672
252,516
290,033
Cash flow
Cash from operating activities
24,789
24,956
36,579
CAPEX
(10,579)
(10,216)
(13,539)
Cash from investing activities
(6,652)
(3,856)
(10,223)
Cash from financing activities
(18,445)
(23,375)
(22,459)
FCF
22,373
33,512
13,932
Balance
Cash
15,120
15,428
17,703
Long term investments
4,844
4,450
4,156
Excess cash
Stockholders' equity
121,245
88,062
63,956
Invested Capital
495,776
456,185
465,644
ROIC
10.71%
6.62%
5.17%
ROCE
10.85%
8.52%
8.10%
EV
Common stock shares outstanding
47,523
46,813
46,690
Price
17.66
-12.88%
20.27
-9.14%
22.31
-15.84%
Market cap
839,256
-11.55%
948,900
-8.90%
1,041,654
-12.63%
EV
1,091,920
1,206,112
1,336,239
EBITDA
70,939
57,963
58,183
EV/EBITDA
15.39
20.81
22.97
Interest
13,430
11,570
9,152
Interest/NOPBT
24.35%
28.36%
23.07%